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A PREVIOUS study ofthe intermediary metabolism of 3: 4-benzpyrene has been
reported (Harper, 1958b). The X1 metabolite (BPX1) was considered to be the
glucuronide conjugate of F1, to which a free phenolic nature was assigned, and
evidence was obtained that 8-benzpyrenol is also eliminated in conjugated form
in the bile. The X2 metabolite (BPX2) was not identified but its absorption
spectrum was considered to be more in keeping with a fully aromatic benzpyrenoid
configuration rather than the dihydroxy-dihydro structure proposed by Weigert
and Mottram (1946).
Conjugation with glucuronic and sulphuric acids is known to be a general
process forthe detoxificationof phenols. It seemedhopeful therefore that reintro-
duction of 8-benzpyrenol and the F1 phenol into the animal body would lead
to their elimination in the bile or urine in conjugation with these two acids. These
conjugates could then be used as reference compounds for the fractionation and
subsequent identification of the intermediate metabolites of 3: 4-benzpyrene.
MATERIALS AND METHODS
8-Benzpyrenol was synthesised by the method ofCook, Ludwiczak and Schoen-
tal (1950). Final purification was effected by chromatography on alumina from
benzene followed by crystallisation from benzene-light petroleum. The resulting
yellow needles melted at 225-228o C. (decomp.) and spectroscopically appeared
almost identical to 8-benzpyrenol of metabolic origin (Berenblum, Crowfoot,
Holiday and Schoental, 1943; Weigert and Mottram, 1946).
The absorption maxima (in ethanol) were at 228, 259, 268, 293-294, 308,
346, 362, 380-5, 402 and 426 m/t. There is a slight displacement of these figures
from those reported by Conney, Miller and Miller (1957) for synthetic 8-benz-
pyrenol in ethanol.
The phenol was prepared for injection as a fine colloidal dispersion containing
0.5 mg. per c.c. by dissolving it in a small volume of acetone and injecting the
acetone solution beneath the surface of glass double-distilled water. The acetone
was then pumped off in vacuo. The mice (Strong A strain) in batches of 10-15
received an intravenous injection of 0 5 c.c. of this colloid and were then killed
at intervals of 1-4 hours.
The F1 phenol was obtained by acid hydrolysis of pooled X1 metabolite
isolated from the small intestines of mice which had been injected with 3: 4-
benzpyrene. It was prepared as a colloidal dispersion as described for 8-benz-
pyrenol and this was used for the injection of four mice.K. H. HARPER
After the desired time interval the particular organ to be examined was quickly
dissected out and subjected to an extraction procedure similar to that described
for the intermediate metabolites of 3: 4-benzpyrene. This involved initial extrac-
tion with 70 per cent acetone, removal of the acetone in vacuo and saturation of
the aqueous phase with ammonium sulphate. After repeated extraction with
xylenetheaqueousphase wasthenacidifiedwithhydrochloric acidandre-extracted
with xylene. This resulted in the transference of all blue fluorescent material
into the xylene phases. These were then combined and chromatographed on
columns of silica gel for the removal of possible X-type derivatives. Free phenol
and quinone in the filtrate from this adsorbent were detected by chromato-
graphy on alumina.
All descriptions of fluorescence refer to the appearance under ultra-violet
light.
fi-Glucuronidase (bacterial) and p-nitrophenylsulphate were obtained from
the Sigma Chemical Company, Missouri, potassium hydrogen saccharate from
George T. Gurr Ltd., silica gel (100/200 mesh), adenylic acid, a-ketoglutaric
acid and adenosinetriphosphate (ATP) from L. Light and Co. Ltd. and alumina
from B.D.H. Ltd. Takadiastase was a gift from Parke Davis, Co. Ltd.
All organic reagents 'were obtained free from fluorescence by fractional
distillation.
RESULTS
Metabolism of 8-benzpyrenol
The appearance of the opened abdominal cavity under ultra-violet light was
very similar to that arising from the intravenous injection of the parent hydro-
carbon, 3: 4-benzpyrene. A strong blue fluorescence was associated with the gall
bladder, gut and kidney but the weak fluorescence of the bladder suggested that
little excretion of fluorescent metabolities was taking place in the urine.
(a) Duodenum and small intestine.-Chromatography of the xylene extract on
silica gelyielded agreen coloured, strongblue/white fluorescent zone at the surface.
On development with amyl alcohol a strong blue fluorescent fraction passed down
the column and was collected in the filtrate, the initial yellow non-fluorescent
fraction being discarded.
The amylalcoholfiltrate was dilutedwith 10 times its own volume ofpetroleuni
ether (b.p. 40-60° C.) and rechromatographed on silica gel. The bright blue
fluorescent metabolite was held as an almost colourless zone at the surface from
which it was readily eluted with ethanol. The absorption spectrum of the eluate
was similar to, but not identical with, the X1 metabolite derived from 3: 4-
benzpyrene (Fig. 1, Table I).
After development with amyl alcohol the whole of the original silica gel
column possessed a blue/white fluorescence, this being most intense in the green
coloured surface zone. On elution with ethanol this surface zone yielded a pale
green solution with an intense blue fluorescence. Its absorption spectrum was
similar to that of X2 derived from 3: 4-benzpyrene but it obviously contained
strongly absorbing background material. Partial purification was effected by
transfer to water, acidification with hydrochloric acid and extraction with ether.
The metabolite passed out in the ether phase and possessed the spectrum shown
(Fig. 2, Table I).
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FIG. 1.-Absorption spectra in ethyl alcohol. 1. X1 metabolite of 3: 4-benzpyrene (upper
scale). 2. X1 metabolite of 8-benzpyrenol (lower scale).
A trace amount only of free 8-benzpyrenol was detected on the alumina
chromatogram.
TABLE I
Absorption maxima in ethanol-Irnj
BPX1 . . 256 266 - 286 298 363 369 379 388 408-409
8-OH.X1 256-257 268 279 289 302 362 369 381 388 409
F1X1 . - - 298 362 369 378-380 406-410
inf. inf. inf.
BPX2 256-260 268 - 287 298 362-364 380 392 414
8-OH.X2 256 268 - 290 303 362 381 392 416-417
BPX1 and BPX2 = X1 and X2 metabolites of 3: 4-benzpyrene.
8-OH.X1 and 8-OH.X2 = X1 and X2 metabolites of 8-benzpyrenol.
FiX, = X1 Metabolite of the F,-phenol.
(b) Caecum and large intestine.-Extracts from animals killed 1 hour after
injection yielded only small amounts of the X-type derivatives and free 8-benz-
pyrenol. The amount of free phenol increased progressively with time and a
considerable quantity was present 4 hours after injection.
(c) Bile.-Extraction of the bright blue fluorescent bile with ether removed
little fluorescent material but after acidification an ether extract possessed a
bright blue fluorescence. After transfer to xylene and chromatography on silica
gel followed by alumina X1- and X2-type derivatives were identified on the silica
gel and free 8-benzpyrenol on the alumina. The extraction of free phenol only
after acidification suggested its formation from an acid-labile precursor. This
factor will be referred to later.
647(d) Kidney.-Appreciable amounts of both X1- and X2-type derivatives were
obtained from this tissue.
(e) Bladder.-A small amount of 8-benzpyrenol was extractable directly from
the urine by ether. Only small amounts of the X-type derivatives and free phenol
were extracted after acidification.
(f) Liver.-Little blue fluorescent material was extracted with 70 per cent
acetone and the Xl-type derivative only was identified with any certainty.
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FIG. 2.-Absorption spectra in ethyl alcohol. 1. X2 metabolite of 3: 4-benzpyrene (upper scale).
2. X2 metabolite of 8-benzpyrenol (lower scale).
Properties and identification of the metabolites
The physical and chemical properties of the two derivatives closely paralleled
those previously reported for the X-metabolites of 3: 4-benzpyrene (Weigert
and Mottram, 1946; Harper, 1958b).
Both were adsorbed on silica gel from xylene and the Xl-type only was eluted
with amyl alcohol. The X2-type was associated with the coloured surface zone of
the chromatogram and was only partially eluted with ethanol. Better elution was
effected with either 1: 1 ethanol-pH 6 phosphate buffer or ethanol containing a
few drops ofhydrochloric acid.
Both were strongly adsorbed on alumina and the Xl-type only was partially
removed by ethanol.
Bothwerewatersolublealthougha certainamountofinsolublematterremained
on evaporating the ethanolic eluates to dryness.
On gently warming in 0 1 N-HCI under nitrogen the Xl-type was rapidly
converted to 8-benzpyrenol whereas the X2-type remained unaffected. With
stronger acid (10 N-HCI) and heating the solution at 100° C. for 2 hours under
nitrogen the X2-type was also converted to 8-benzpyrenol.
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Further investigation of the hydrolytic conditions revealed that, after the
addition of acid to an aqueous solution of the Xl-type metabolite, although
there was no apparent change in its absorption spectrum, a considerable amount
of free 8-benzpyrenol was immediately extractable with ether. It appeared
therefore that the metabolite was instantly decomposed by the combined effect
of acid and ether.
The most likely explanation for this behaviour was that the metabolites were
sulphate and glucuronide conjugates of 8-benzpyrenol for, in an analogous study
of the metabolism of 1-naphthol (Boyland and Wiltshire, 1953), the phenol was
excreted either as free naphthol, naphthylsulphuric acid or naphthylglucuronide
and only a relatively small amount was degraded by metabolic processes in the
animal body. The evidence thus far pointed towards the Xl-type derivative
being the sulphate and the X2-type the glucuronide for phenylglucuronides are,
in general, more resistant to acid hydrolysis than are the sulphates (Bray and
Thorpe, 1954) and, in the case of steroid conjugates, the glucuronides are more
strongly adsorbed on alumina than are the sulphates (Barlow, 1957).
Experiments were therefore carried out to test this hypothesis.
Testfor the glucuronide moiety
Solutions of the metabolites in 2 c.c. water (estimated as containing as much
as 25 y) were heated with 2 c.c. 0 375 per cent naphthoresorcinol reagent and
4 c.c. technical hydrochloric acid at 1000 C. for 2 hours. The mixtures were then
cooled and extracted with 10 c.c. ether. The ether extract of the Xl-type was
pale yellow in colour although a reddish tinge was given by impure samples ofthe
metabolite contaminated by yellow colouring matter. The X2-type invariably
yielded a reddish/blue colour.
Although not conclusive this suggested a glucuronide moiety in the X2-type
derivative.
Action of f8-glucuronida8e
Detailedstudiesoftheenzyme,8-glucuronidase andofitsinhibitionby saccharo-
1: 4-lactone have been made by Levvy and his co-workers (Levvy, 1948, 1952;
Karunairatnam and Levvy, 1949) and the statement is made (Conchie and
Levvy, 1957) that saccharo-1: 4-lactone as such, or in the form of a saccharate
solution, has been shown to inhibit f8-glucuronidase from every source that has
been studied.
Incubations of the metabolites with fl-glucuronidase were carried out as
described in the Sigma Bulletin No. 105 using a 1 per cent solution ofthe enzyme.
In control experiments boiled 1 per cent solutions were used. The incubates were
then cooled and extracted with ether.
The extracts from the control and Xl-type incubates were only weakly
fluorescent whereasthatfromthe X2-type wasbrightblueandexhibitedthe charac-
teristic spectrum of 8-benzpyrenol.
In the presence of 10-2 M boiled saccharate solution thehydrolytic effect ofthe
enzyme on the X2-type metabolite was almost completely abolished.
This result indicated a f-glucuronosidic linkage in the X2-type derivative
only.
649K. H. HARPER
Action of takadiastase
A detailed investigation of the arylsulphatase activity of takadiastase was
made by Robinson, Smith, Spencer and Williams (1952).
The optimum pH for arylsulphatase activity appears to be about 6 but in the
present experiments acetate buffer pH 6-8 was used in order to eliminate possible
pH effect on the metabolites. Under these conditions the takadiastase still pos-
sessed appreciable activity towards p-nitrophenylsulphate as substrate but the
activity was bolished on boiling the enzyme solution for 15 minutes.
Incubations were carried out as described by Robinson et al. using the boiled
enzyme as control. The incubates were then cooled and extracted with ether.
The extracts from the control and X2-type incubates were only weakly
fluorescent whereas that from the Xl-type was bright blue and exhibited the
characteristic spectrum of 8-benzpyrenol.
An arylsulphate linkage was thus indicated in the X1-type metabolite only.
Liver slice experiments
The conjugation of phenols with sulphuric and glucuronic acids in isolated
liver slices has been reported by Storey (1950), De Meio and Tkacz (1952).
Fifteen grammes mouse liver slices were incubated in 50 c.c. Tyrode buffer
containing 1 mg. 8-benzpyrenol with oxygenation. The slices soon assumed a
bright blue fluorescence and after 2 hours were extracted as described for the
in vivo tissue.
Appreciable amounts of both X1- and X2-type derivatives and benzpyrene-
5: 8-quinone were identified on the chromatograms in addition to unchanged
8-benzpyrenol.
Glucuronide synthesis in liver homogenate
The failure of liver homogenates to synthesise glucuronides was studied by
Dutton and Storey (1954). They found that glucuronide synthesis could be
restored by the addition of an extract of boiled liver to the homogenate and
subsequent work led to the identification of the essential factor as being uridine
disphosphate glucuronic acid (UDPGA) (Storey and Dutton, 1955).
An investigation of the metabolism of 8-benzpyrenol in mouse liver homo-
genate was first made under the conditions described for liver slices. Under these
conditions a small amount ofthe X1-type derivate only was identified on the silica
gel chromatogram. Free phenol and 5: 8-quinone were obtained on the alumina
column.
Experiments were then made with liver homogenate fortified by the addition
of crude UTDPGA prepared from guinea-pig liver (Dutton and Storey, 1954).
A 10 per cent mouse liver homogenate was prepared in 0*154 M-KCI containing
3*2 X 104 M KHCO3. Incubations were then carried out at 370 C. with 30 c.c.
homogenate to which was added 20 c.c. 0-2 M phosphate buffer pH 7*4, 25 mg.
ascorbic acid in 12 c.c. water, 6 c.c. 0*3 M MgC12, 5 c.c. of colloidal 8-benzpyrenol
containing 1-25 mg., 35 c.c. of crude UDPGA extract and 50 c.c. water. In a
control experiment the UDPGA extract was substituted by 35 c.c. water. After
2 hours the incubates were extracted as described for the in vivo tissue.
The extract of the fortified homogenate yielded a wide bright blue fluorescent
zone at the surface of the silica gel which was absent from the control column.
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Little blue fluorescent material was removed from this zone on prolonged develop-
ment with amyl alcohol. On elution with ethanol it was identified as the X2-type
metabolite by its conversion to 8-benzpyrenol both by fl-glucuronidase and pro-
longed acid hydrolysis.
Considerable amounts ofthe 5: 8-quinone were obtained from both the experi-
mental and control incubates, possibly due to oxidation of the phenol by ascorbic
acid (cf. Warren, 1943).
It is concluded therefore thatformation ofthe X2-type metabolite is dependent
upon the presence ofUDPGA and in this respect conforms to accepted knowledge
concerning the synthesis of glucuronides.
Sulphate 8ynthesi8 in liver honwqenate
Following on from preliminary work on the synthesis of sulphates in liver
homogenate (De Meio and Tkacz, 1950, 1952; De Meio and Wizerkaniuk, 1952;
De Meio, 1952) it was shown by Bernstein and McGilvery (1952) and De Meio,
Wizerkaniuk and Fabiani (1953) that the enzyme system is located in the high
speed supematant fraction of the homogenate and requires ATP and Mg++ ions
for activity.
In the present experiments a 10 per cent mouse liver homogenate in Tyrode
buffer (60 c.c.) was fortified with 20 c.c. 0154 M MgSO4 and 10 mg. ATP (sodium
salt) and incubated with 0 5 mg. of 8-benzpyrenol at 370 C. for 2 hours. In a
control expriment ATP was omitted from the mixture.
After extraction the Xl-type derivative only was identified with any certainty
in the control experiment. The ATPfortifiedhomogenatehowever, yieldeda much
increased yield of the Xl-type derivative and a smaller zone of what appeared
to be the X2-type. On elution with ethanol however, this latter fraction exhibited
predominantly the absorption spectrum ofthe Xl-type metabolite suggesting that,
in the absence of much X2-type derivative, the Xl-type is only partially removed
from silica gel by amyl alcohol. This provides a possible explanation for the
appearance of the chromatogram noted for tissue extracts of animals injected
with 8-benzpyrenol (this paper) and 3: 4-benzpyrene (Harper, 1958b).
After elution with ethanol, further blue fluorescent material was removed
from the X2-type zone by 1: 1 ethanol-phosphate buffer but insufficient was
obtained for characterisation.
Contrary to the findings of De Meio, Wizerkaniuk and Fabiani (1953) with
respect to the synthesis of phenyl-sulphate in liver homogenate, replacement
ofthe ATP by a mixture ofadenylic and o-ketoglutaric acids did not increase the
yield ofthe Xl-type metabolite.
Experiments using fortified " microsome free " supernatant fractions of the
homogenate have given varied results. An initial preparation gave excellent yields
of the Xl-type metabolite only. In repetitive experiments however, the account
of the Xl-type derivative varied considerably being practically zero on occasions.
No explanation for this behaviour can be offered but it is possibly due to technical
errors inherent in the establishment of the in vitro sulphate synthesising system.
No definite conclusion can therefore be arrived at from these experiments
but it is considered significant that, on the occasions when evidence of increased
metabolismhasbeenobtained, theXl-typederivativehasbeenpresentasthemajor
metabolite.
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Metabolism in cat liver slices
Certainevidence exists to suggestthat catliverdoesnot synthesiseglucuronides
(Hartiala, 1955; Dutton and Greig, 1957). In addition no glucuronides could be
isolated from the urine of cats fed various glucuronidogenic substances (Professor
R. T. Williams, private communication quoted by Dutton and Greig, 1957.)
Fifty grammes young cat liver were sliced and incubated in 100 c.c. Tyrode
buffer containing 0 3 M MgSO4 and 1-25 mg. 8-benzpyrenol with oxygenation.
Afterextraction a considerable amount ofthe Xl-type metabolite was obtained
on the chromatogram. Once again however, a blue fluorescence was associated
with the X2-type zone. Its ethanol eluate was only weakly fluorescent and its
absorption spectrum was more like that of the Xl-type metabolite. Also, unlike
the X2-type, it did not give a coloured ether extract in the naphthoresorcinol
test for glucuronic acid.
If the evidence that cats do not produce glucuronides is correct then this
result isinaccordance withtheviewthatthe X2-typemetabolite is theglucuronide.
The possibility of the Xl-type being so is eliminated.
The biosynthesis of 35S-labelled Xl-type metabolite
The involvement of inorganic sulphate in the synthesis of ethereal sulphates
receives considerable support from the studies of Laidlaw and Young (1953) who
observed the excretion of radioactive 2-naphthylsulphuric and 2-amino-i-
naphthylsulphuric acids after the simultaneous injection of 35S-labelled inorganic
sulphate and 2-naphthol and 2-naphthylamine respectively.
A similar synthesis of 35S-labelled phenylsulphate in liver slices was reported
by Sato, Suzuki and Yoshikawa (1953).
In the present experiments 30 g. of mouse liver were sliced and incubated at
370 C. for 3 hours in 150 c.c. Tyrode buffer containing 1*25 mg. 8-benzpyrenol
and 0*9 mc. Na2 35SO4 with oxygenation. In a control experiment 8-benzpyrenol
was omitted from the mixture.
The slices were then extracted and the distribution ofradioactivity determined
in the X1- and X2-type derivatives and corresponding fractions from the control
experiment.
The association of radioactivity with the metabolites was then determined
after heating their aqueous solutions under nitrogen in 0-1 N-HCI for 15 minutes,
saturating with ammonium sulphate and extracting with ether. Under these
conditions 8-benzpyrenol was removed from the X1-type solution whereas the
X2-type derivative was extracted practically unchanged. The ether extracts
were then transferred to 2 c.c. water and their activity determined.
The results of these experiments are shown in Table II.
TABLE II
Counts per minute
Ethanol eluates Ether extracts of acid
transferred to 4 c.c. hydrolysates transferred
water to 2 c.c. water
8-Benzpyrenol X1. 1190 67
Control Xl-zone . 60 38
S-Benzpyrenol X2. . 469 76
Control X2-zone . 328 68
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The results indicate a close association of radioactivity with the Xl-type
metabolite.
The fact that the activities of the X2-type zones from the experimental and
control runs are ofthe same order and the fact that this activity is removed under
conditions which leave the metabolite unchanged suggests that the activity is
due to the presence of 35S-labelled material unconnected with the metabolism
of the phenol.
Summary of results
The following facts are considered to establish the identity of the X2-type
metabolite as 8-benzpyrenylglucuronic acid:
(1) Its chromatographic behaviour (cf. Barlow, 1957).
(2) Its relative stability to acid hydrolysis (cf. Bray and Thorpe, 1954).
(3) The colour reaction with naphthoresorcinol reagent.
(4) Its hydrolysis to 8-benzpyrenol by ,6-glucuronidase and the inhibition of
this hydrolysis by 10-2 M boiled saccharate solution.
(5) Its synthesis in liver homogenate fortified with crude UDPGA.
(6) The apparent inability of cat liver slices to effect its synthesis.
The following facts are considered to establish the identity of the Xl-type
metabolite as 8-benzpyrenylsulphuric acid:
(1) Its chromatographic behaviour (cf. Barlow, 1957).
(2) Its instability to acid (cf. Bray and Thorpe, 1954).
(3) Its hydrolysis to 8-benzpyrenol by takadiastase.
(4) Its synthesis in liver homogenate fortified with ATP and the less consistent
results of the " microsome free " supernatant experiments.
(5) Thesynthesisof35S-labelledXl-typemetabolitebyliverslicesinthepresence
ofNa2 35SO4.
Metabolism of the Fl-phenol
The small quantity ofthe phenol available has severelylimitedits experimental
use so that it has not been possible to confirm the results by repetition.
The general appearance of the opened abdominal cavity was similar to that
after 8-benzpyrenol. The intensity of the fluorescence was much reduced by
comparison however, presumably due to the much lower dosage level.
Gall bladder, duodenum and small intestine
The combined gall bladder, duodenum and small intestine were extracted as
described for 8-benzpyrenol. On chromatographic separation similar blue fluores-
cent X1- and X2-type fractions were obtained.
The ethanol eluate of the Xl-type zone possessed only weak absorption but
pronounced maxima were present at 298 and 378-380 m,u with inflections at 362,
369 and 406-410 m,u (Table I). On acidification with hydrochloric acid and gentle
warming under nitrogen it was converted back into the Fl-phenol as shown by
the appearance of the 418 m,u bandinthe absorption spectrum and the fluorescent
colour change from blue to green in sodium hydroxide.
Strongly absorbing background material prevented possible characterisation
of the X2-type metabolite by absorption spectroscopy but, on transfer to water
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and incubation with /8-glucuronidase, an ether extract exhibited the characteristic
absorption spectrum of the Fl-phenol.
In view of this evidence and by analogy with the behaviour of 8-benzpyrenol
it is concluded that the Fi-phenol is similarly conjugated with sulphuric and
glucuronic acids.
RE-EXAMINATION OF THE METABOLISM OF 3: 4-BENZPYRENE AND PYRENE
(a) 3: 4-Benzpyrene
Identification of the X1-type metabolite of 8-benzpyrenol as the sulphate
conjugate is in direct conflict with previous evidence suggesting the presence of
a /)-glucuronosidic linkage in the X1 metabolite derived from 3: 4-benzpyrene.
The discovery that 8-benzpyrenylsulphuric acid is instantly decomposed by
acid and ether suggested a possible explanation for this discrepancy for in the
previous series ofexperiments, afterincubation with ,-glucuronidase, the solutions
were routinely acidified with hydrochloric acid to facilitate removal of the phenol
by ether. It was essential therefore to repeat those experiments under the same
conditions used for the 8-benzpyrenyl metabolites.
Effect of acid.-On acidification of the aqueous solution of the metabolites
free Fl-phenol was immediately extractable from the BPX1 solution with ether.
The BPX2 metabolite tended to form a scum at the interface but spectroscopically
appeared to be unchanged.
The BPX2 was then heated in 10 N-HCl at 1000 C. under nitrogen for 2 hours.
An ether extract of the hydrolysate was yellow in colour with a bright blue
fluorescence. It absorption spectrum was predominantly that of the Fl-phenol
but attenuation of the 395 and 418 m,u bands suggested the presence of some
8-benzpyrenol. This was verified on transfer to hexane when the 396 and 419-420
m#u bands of 8-benzpyrenol appeared in the F1 spectrum.
In a further experiment the ether extract of the BPX2 hydrolysate was trans-
ferred to xylene and chromatographed on a column of silica gel over alumina
when the phenolic fraction was obtained as a bright yellow/green fluorescent
zone on the alumina. The absorption spectrum of the ethanol eluate from this
zone was predominantly that ofthe Fl-phenol but an additional band at 425-426
m1tt indicated the presence of 8-benzpyrenol.
Thus, behaviour so far was similar to that of the 8-benzpyrenyl conjugates.
A further phenomenon was observed however in the case of the BPX2 on acid
hydrolysis. Thexylene filtratefromthesilicagel/alumina chromatograminvariaby
possessed a blue/violet fluorescence. On evaporating the filtrate to dryness and
dissolving the residue in ethanol the characteristic absorption spectrum of 3: 4-
benzpyrene was obtained.
Tests for glucuronic acid.-Solutions of the metabolites were heated with
naphthoresorcinol reagent as described for 8-benzpyrenol. Similar colorations
were obtained on extraction with ether suggesting the presence of a glucuronide
moiety in BPX2 only.
Effect of 8-glucuronida8e.-After incubation with fi-glucuronidase a trace
amount only of the Fl-phenol was removed from the BPX1 solution by direct
extraction with ether. A similar trace was obtained from the boiled enzyme
control.
The BPX2 incubate however, yielded a bright blue fluorescent ether extract
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which was not obtained from the boiled enzyme control. The presence ofFl-phenol
and a smaller amount of8-benzpyrenolintheextract was determinedbyabsorption
spectroscopy after transfer to hexane.
Effect of takadiastase.-Little blue fluorescent material was extracted from the
BPX2 solution by ether after incubation with takadiastase. The BPX1 solution
however, yielded a bright blue fluorescent extract exhibiting the characteristic
absorption spectrum of the Fl-phenol. This contrasted markedly with the weak
blue fluorescent extract when the boiled enzyme was used.
Nature ofBPX1 and BPX2.-The above results invalidate previous conclusions
as to the nature ofthe X1 metabolite of 3: 4-benzpyrene but confirm the presence
of a ,-glucuronosidic linkage in the X2 metabolite.
Inviewofthisevidence,andbyanalogywiththebehaviourofthe 8-benzpyrenyl
metabolites, it is concluded that BPX2 is a complex mixture containing at least
three derivatives, the glucuronide of F1, the glucuronide of 8-benzpyrenol and
an acid-decomposable benzpyrene precursor.
The behaviour of BPX1 is in accordance with it being the sulphate conjugate
ofF1 only as 8-benzpyrenol has not, so far, been identified by absorption spectro-
scopy as a product ofits hydrolysis. The possibility of a small amount of 8-benz-
pyrenol being present in the F1 cannot entirely be ruled out however, for in a
parallel case, Conney, Miller and Mller (1957) have-reported that a methylated
metabolite possessing the characteristic absorption spectrum of 8-methoxybenz-
pyrene did in fact contain some of the 10-methoxyderivative.
Attempted fractionation of BPX1 by partition chromatography has failed to
establish the presence of 8-benzpyrenyl-sulphuric acid. Such a result is not
surprising perhaps in view ofthe very similar properties of, and the close spectral
relationship between, the metabolites and the fact that only a small amount
of free 8-benzpyrenol appears in the caecum and large intestine during the first
few hours following intravenous injection of 3: 4-benzpyrene.
It seemed possible that more direct evidence for its presence would be afforded
by an investigation ofthe BPX1 obtained after the intraperitoneal injection ofthe
hydrocarbon for, under these conditions, the amount of 8-benzpyrenol initially
appearing in the faeces is increased (Weigert and Mottram, 1946). Accordingly
the X1 metabolite was isolated from the small intestines of mice killed 6 hours
after the intraperitoneal injection of 1 mg. of 3: 4-benzpyrene. There was no
marked difference in its absorption spectrum but, on mild acid hydrolysis, a
mixtureofF1and 8-benzpyrenolwasobtainedas shownbythepresenceofdoublets
in the absorption spectrum at 392 and 396 m,t and 415 and 419-420 m,l in hexane
as solvent (Harper, 1958b).
This fact therefore is considered to provide good evidence for the metabolic
formation of 8-benzpyrenylsulphuric acid from 3: 4-benzpyrene.
Attempts to fractionate the BPX2 complex were equally unsuccessful in that
separation into the respective glucuronides was not achieved. It was established
however, that the hydrocarbon precursor is concentrated in a narrow tan coloured
surface zone of the chromatogram and its presence appears to be associated with
the appearance of a 346 m,g maximum in the BPX2 absorption spectrum (Fig. 3).
Successive lower fractions of the zone possessed similar absorption spectra but
slight variations in the position of the absorption maxima were noted. The
significance of these shifts has not been established but it is suggestive of the
presence of more than one metabolite.
655K. H. HARPER
The absorption spectrum of BPX2 obtained in the filtrate after development
ofthe chromatogram with ethanol is also recorded here (Fig. 3) as it is,considered
to establish the fully aromatic benzpyrenoid configuration of the metabolite.
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Fia. 3.-Absorption spectra in ethyl alcohol. BPX, fractions: 1. Ethanol filtrate.
2. Top surface zone. (For explanation see text.)
(b) Pyrene
In a previous study of the metabolism ofpyrene two intermediate metabolites
were isolated (Harper, 1958a). One was identified as 3-pyrenylglucuronic acid
and appeared to be the major metabolite excreted in the bile. The other, signified
as PX, was only obtained from the in vivo liver but was formed, together with the
glucuronide and free phenol, from pyrene in isolated liver slices. It was rapidly
decomposed to 3-hydroxypyrene by acid and in view of the similar behaviour
foundfor 8-benzpyrenylsulphuric acid thepossibility ofit being 3-pyrenylsulphuric
acid has been tested.
Separation ofthe pyrene metabolites inthe small intestine into X1 and X2-type
fractions was carried out as described for 8-benzpyrenol.
The X2 zone yielded a blue/violet fluorescent solution exhibiting the charac-
teristic absorption spectrum of 3-pyrenylglucuronide. This was confirmed by its
hydrolysis to 3-hydroxypyrene both by /J-glucuronidase and acid. The presence
of a small amount offree pyrene in the acid hydrolysate was also established by
xylene extraction followed by chromatography on silica gel over alumina. This is
in accordance with the presence of an acid-labile precursor of pyrene previously
reported in the faeces (Harper, 1957).
The X1 zoneyielded apalebluefluorescentsolutionexhibiting the characteristic
absorption spectrum of PX. The PX remained unaffected on incubation with
fl-glucuronidase but was rapidly hydrolysed to 3-hydroxypyrene by takadiastase.
It is concluded therefore that PX is 3-pyrenylsulphuric acid and that, in like
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manner to 8-benzpyrenol, 3-hydroxypyrene is eliminated in the bile in conjugation
with both glucuronic and sulphuric acids.
OTHER HYDROCARBONS
In the case of two other hydrocarbons, chrysene and 20-methylcholanthrene,
the same pattern ofbiliary excretion has been observed. X1- and X2-type deriva-
tives have been isolated from the duodenum and small intestine and these have
undergone hydrolysis to phenolic compounds in the caecum and large intestine.
An acid-decomposable precursor of 20-methylcholanthrene has also been
found in its X2 complex.
DISCUSSION
Although the absolute identification of the metabolites of 3: 4-benzpyrene
must eventuallylie in their individual isolation and characterisation, withchemical
synthesis as the final check, the results of these experiments are considered to
provide good evidence for the presence of sulphate and glucuronide conjugates
of the F,-phenol and 8-benzpyrenol in the mixture of metabolites excreted via
the gall bladder. The formation ofsuch compounds was ofcourse to be anticipated
from the metabolic studies carried out by Conney, Miller and Miller (1957). These
workers investigated the metabolism of 3: 4-benzpyrene in fortified liver homo-
genate and identified 8-benzpyrenol, 10-benzpyrenol and the Fl-phenol as major
products ofoxidation. As 10-benzpyrenol has also been identified as an excretion
product of 3: 4-benzpyrene in the faeces (Berenblum and Schoental, 1946) a
similar sequence ofconjugation and hydrolysis is to be anticipated but the present
experiments have yielded no evidence on this point. In this connection it is
perhaps significant that Chalmers (1956), using more refined paper partition
chromatographic methods, has isolated a metabolic fraction possessing an absorp-
tion spectrum suggestive of 10-methoxybenzpyrene and giving a positive test for
glucuronic acid.
The fact that the F,-phenol has not been detected as an excretion product of
8-benzpyrenol in these experiments suggests that it is formed as a separate entity
during the primary oxidation of 3: 4-benzpyrene in the liver. The findings of
Conney, Miller and Miller (1957) previously referred to are consistent with this
view. If this is the case then a possible metabolic sequence would be as in Fig. 4.
3: 4-BENZPYRENE
8-Benzpyrenol 10-Benzpyrenol F1
2 12 2
Glucuronide Sulphate Glucuronide Sulphate Glucuronide Sulphate
43 13 3
8-Benzpyrenol 10-Benzpyrenol F1
14 14 14
5: 8-Quinone 5: IO-Quinone Quinone
FIG. 4.-i. Oxidation by microsome/TPNH system of tissue. 2. Conjtugation with glucuronic
and sulphuric acids. 3. Hydrolysis in caecum and l8rge intestine. 4. Partial oxidation to
quinones.
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The.unknown factors in this scheme are the identity of the Fl-phenol and the
mechanism by which the sulphate conjugates are hydrolysed in the gut. No new
evidence has been forthcoming on the former point but the acid-labile nature of
the sulphate conjugates suggests that possible pH changes down the gut could
play a part in their hydrolysis, as suggested by Weigert and Mottram (1946).
The other possibility is hydrolysis by arylsulphatase activity, and on this point
no conclusive information appears to exist. Dodgson, Spencer and Thomas
(1953)reportedthattheintestinepossessed butlittlearylsulphatase activity but this
result was based on the activity of only small pieces of the intestine, the exact
location ofwhich was not stated. Indeed, in view of the fact that a spectrophoto-
metric method of assay was used, it is unlikely that the highly coloured caecal
contents would be amenable to such an investigation.
Obviously further work must be done to establish this point but it is perhaps
significant that certain strains ofbacteria have beenfound to possess arylsulphatase
activity (e.g. Whitehead, Wildy and Engbaek, 1953).
The failure of Gutmann and Wood (1950) to obtain evidence of 35S-labelled
metabolites of 3: 4-benzpyrene from the urine of animals previously dosed with
35S-labelled L-cystine and DL-methionine appears to be at variance with the
biosysnthesis of radioactive 8-benzpyrenylsulphuric acid reported here. It must
be borne in mind however that only a relatively small percentage (17 per cent
according to Heidelberger and Weiss, 1951) ofinjected 3: 4-benzpyrene is elimin-
ated in the urine. The present experiments suggest that only a small fraction of
this can be attributed to the presence of the sulphate conjugates and of course
further hydrolysis to the phenols presumably takes place during the collection
period. It is doubtful therefore whether such a small increase in activity would be
detected in an experiment where an appreciable standard deviation existed.
In the same experiment the failure to obtain evidence of increased excretion of
radioactivity in the faeces can be explained by resorption of the sulphate radicals
after hydrolysis of the conjugates in the caecum. That the colon is an active site
ofsulphate fixation is shown by the work ofPasternak, Kent and Davies (1958),
and Pasternak and Kent (1958).
The identification ofthe X1 and X2 metabolites of3: 4-benzpyrene as sulphate
andglucuronide conjugates respectively can now be correlated with thefindings of
Calcutt and Payne (1954) with respect to the intracellular distribution of the
metabolites in the liver.
The sulphate synthesising system is located in the supernatant fraction of the
homogenate and it was in this fractiononly that the X1 metabolite was detected.
Thesystemresponsibleforglucuronidesynthesis onthe otherhand, is located in
the microsomal fraction (Dutton andStorey, 1954; Strominger, Kalckar, Axelrod
and Maxwell, 1954), but a lower level ofactivity is also associated with the mito-
chondrial and nuclear fractions (Dutton, 1956). Calcutt and Payne obtained the
X2 metabolite from all fractions but Calcutt (private communication) considers
the bulk of the metabolite to be located in the microsomes.
The identification of 3-pyrenyl glucuronic and sulphuric acids as biliary
excretion products of pyrene and their hydrolysis to 3-hydroxypyrene in the
caecumandlarge intestinesuggeststhatthismetabolicsequencemay be a common
pattern of excretion amongst the polycyclic hydrocarbons. This is borne out by
theisolationofX1-andX.-typederivativesofchryseneand20-methylcholanthrene.
Chalmers (1957) has also reported the excretion of conjugated metabolites of
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anthracene in the bile. The possibility of a similar sequence for 1: 2: 5: 6-
dibenzanthracene is suggested by the unchanged excretion in the faeces of the
unidentified phenolic metabolite from the rabbit after its reinjection into mice
(Dobriner, Rhoads and Lavin, 1942).
The formation of acid-labile precursors of the hydrocarbons may also be a
common factor. The excretion of such compounds has already been reported for
a variety of hydrocarbons (Chang and Young, 1943), and a similar behaviour has
now been observed for pyrene, 3: 4-benzpyrene and 20-methylcholanthrene.
SUMMARY
1. The excretions of 8-benzpyrenol and the F1 metabolite of 3: 4-benzpyrene
have been investigated after intravenous injection in the mouse. The same
pattern ofexcretion has been observed as that arising from injection ofthe parent
hydrocarbon i.e., the elimination of X-type derivatives in the bile and their
hydrolysis back to the phenols in the caecum and large intestine.
2. The X1- and X2-type metabolites of 8-benzpyrenol have been identified as
the sulphate and glucuronide conjugates of the phenol respectively and similar
structures are proposed for the metabolites derived from the Fl-phenol.
3. A re-examination of the metabolism of 3: 4-benzpyrene has invalidated
previous conclusions as to the nature of the X1 metabolite (BPX1) but has con-
firmed the presence ofglucuronic acid in the X2 metabolite (BPX2).
4. Evidence has beenobtainedthatBPX2isinfactacomplex mixture containing
the glucuronides of F, and 8-benzpyrenol together with an acid-labile precursor
of 3: 4-benzpyrene.
5. The behaviour ofBPX1 is in accordance with it being the sulphate conjugate
of F1 only but evidence for the presence of 8-benzpyrenylsulphuric acid in the
BPX1 has been obtained after the intraperitoneal injection of the hydrocarbon.
6. A possible metabolic sequence to account for these facts is proposed.
7. A re-examination ofthe metabolism ofpyrene has been made. The hitherto
unidentified metabolite isolated from the liver has now been identified as 3-
pyrenylsulphuric acid and found to be an excretion product in the bile together
with 3-pyrenylglucuronic acid and an acid-labile precursor of the hydrocarbon.
8. Chrysene and 20-methylcholanthrene have yielded similar X1- and X2-type
metabolites undergoing hydrolysis to phenolic products in the caecum. It is
suggested that this may be a common pattern of excretion for the polycyclic
hydrocarbons.
I am much indebted to Mr. F. S. Stewart for his advice on the handling of
radioactive compounds and to Parke Davis, Co. Ltd. for theirgift oftakadiastase.
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